Neogen Corp. of Lansing, Mich., has acquired International Diagnostic Systems Corp., which develops, makes and markets test kits for the detection of drug residue in food and animal feed and drugs in forensic and animal samples. Terms of the deal were not disclosed. Part of IDS’s operations will be moved to and integrated with Neogen’s Lexington, Ky., facilities. IDS’s research and development operations and key employees will remain in St. Joseph, Mich. In addition to U.S. sales, IDS distributes in France, Italy, Spain, Germany and China. The company reported revenue of about $2 million in the most recent fiscal year. “International Diagnostic’s products are complementary and a nice fit with our existing forensic and drug-detection product lines,” said Lon Bohannon, Neogen’s president. “The IDS purchase also provides Neogen with key collaborative relationships with influential industry partners, and increased access to important international markets, including China.” <HOME>
